IOVA

Iovance Biotherapeutics (IOVA)

Iovance Biotherapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IOVA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/21	07 : 00	GlobeNewswire Inc.	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/12/19	07 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/12/14	07 : 16	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/12/05	06 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/12/05	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/12/05	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/12/03	07 : 25	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/11/27	06 : 01	GlobeNewswire Inc.	Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/11/22	07 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/11/08	07 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/11/08	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/11/08	06 : 01	GlobeNewswire Inc.	Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/11/01	05 : 01	GlobeNewswire Inc.	Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/10/17	07 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/10/17	07 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/10/17	07 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/09/06	08 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/09/06	08 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/09/06	08 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/09/06	08 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/09/04	06 : 00	GlobeNewswire Inc.	Iovance Biotherapeutics to Present at Upcoming Conferences	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/08/17	06 : 00	GlobeNewswire Inc.	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/08/10	06 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/08/09	06 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/08/09	05 : 01	GlobeNewswire Inc.	Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/07/30	05 : 01	GlobeNewswire Inc.	Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/07/20	06 : 00	GlobeNewswire Inc.	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/07/18	09 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/07/18	09 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/07/18	09 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc